DK210

DK210 · DEKA Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DK210, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors [Phase 1]